Bedside diagnosis of rippling muscle disease in CAV3 p.A46T mutation carriers

Thirty‐nine members, ages 1 to 67 years, of a Swedish family with rippling muscle disease (RMD) were investigated to assess genotype–phenotype correlations. Clinical, neurophysiological, and muscle morphological examinations were performed. Genetic analysis was performed in 38 individuals. Twenty‐three patients had percussion‐induced muscle mounding (PIMM) and percussion‐induced rapid contractions (PIRC). Rippling and hyperCKemia were not found in all patients. Weakness was minor or absent. The electromyogram showed absence of electrical activity in ripples and PIMM, and muscle biopsy specimens confirmed caveolin‐3 deficiency and absence of caveolae. Genetic analysis revealed a CAV3 c.G136A transition resulting in a p.A46T missense mutation in affected family members. The phenotype in these 23 cases of RMD with this mutation appears to be homogenous, benign, and nonprogressive. The presence of PIMM and PIRC seems to be diagnostic at all ages, whereas the absence of hyperCKemia and rippling does not exclude the diagnosis. Muscle Nerve, 2010

[1]  F. Sotgia,et al.  Caveolinopathies: from the biology of caveolin-3 to human diseases , 2010, European Journal of Human Genetics.

[2]  M. Weber,et al.  Rippling muscle disease: Variable phenotype in a family with five afflicted members , 2010, Muscle & nerve.

[3]  F. Sotgia,et al.  Caveolinopathies: from the biology of caveolin-3 to human diseases , 2009, European Journal of Human Genetics.

[4]  G. Lamb,et al.  Plasma membrane removal in rat skeletal muscle fibers reveals caveolin-3 hot-spots at the necks of transverse tubules. , 2009, Experimental cell research.

[5]  H. Goebel,et al.  Immune-mediated rippling muscle disease with myasthenia gravis: A report of seven patients with long-term follow-up in two , 2009, Neuromuscular Disorders.

[6]  M. Roberts,et al.  Caveolinopathy – New mutations and additional symptoms , 2008, Neuromuscular Disorders.

[7]  K. Tsuchida,et al.  Caveolin-3 regulates myostatin signaling. Mini-review. , 2008, Acta myologica : myopathies and cardiomyopathies : official journal of the Mediterranean Society of Myology.

[8]  Michael J Ackerman,et al.  Novel mechanism for sudden infant death syndrome: persistent late sodium current secondary to mutations in caveolin-3. , 2007, Heart rhythm.

[9]  Michael J Ackerman,et al.  Mutant Caveolin-3 Induces Persistent Late Sodium Current and Is Associated With Long-QT Syndrome , 2006, Circulation.

[10]  K. North,et al.  Rippling muscle disease , 2006, Journal of Clinical Neuroscience.

[11]  G. Lamb.  Rippling muscle disease may be caused by “silent” action potentials in the tubular system of skeletal muscle fibers , 2005, Muscle & nerve.

[12]  C. Angelini,et al.  Molecular and muscle pathology in a series of caveolinopathy patients , 2005, Human mutation.

[13]  J. Finsterer,et al.  A CAV3 microdeletion differentially affects skeletal muscle and myocardium , 2004, Neurology.

[14]  T. Braun,et al.  Myostatin mutation associated with gross muscle hypertrophy in a child. , 2004, The New England journal of medicine.

[15]  S. Woodman,et al.  Caveolinopathies: mutations in caveolin-3 cause four distinct autosomal dominant muscle diseases. , 2004, Neurology.

[16]  K. Ueda,et al.  Identification and functional analysis of a caveolin-3 mutation associated with familial hypertrophic cardiomyopathy. , 2004, Biochemical and biophysical research communications.

[17]  T. Brüning,et al.  Homozygous mutations in caveolin‐3 cause a severe form of rippling muscle disease , 2003, Annals of neurology.

[18]  H. Urbach,et al.  Consequences of a novel caveolin‐3 mutation in a large German family , 2003, Annals of neurology.

[19]  T. Torbergsen.  Rippling muscle disease: A review , 2002, Muscle & nerve. Supplement.

[20]  D. Stephan,et al.  Severe autosomal recessive rippling muscle disease , 2001, Muscle & nerve.

[21]  Romeo Chua,et al.  Human interlimb reflexes evoked by electrical stimulation of cutaneous nerves innervating the hand and foot , 2001, Experimental Brain Research.

[22]  M. Nöthen,et al.  Mutations in CAV3 cause mechanical hyperirritability of skeletal muscle in rippling muscle disease , 2001, Nature Genetics.

[23]  M. Blank,et al.  Dissociation of the dystroglycan complex in caveolin-3-deficient limb girdle muscular dystrophy. , 2000, Human molecular genetics.

[24]  C. Ansevin.  Phenotypic variability in rippling muscle disease. , 2000, Neurology.

[25]  J. Malin,et al.  Phenotypic variability in rippling muscle disease , 1999, Neurology.

[26]  E. Ralston,et al.  Caveolin-3 is associated with the T-tubules of mature skeletal muscle fibers. , 1999, Experimental cell research.

[27]  D. Stegeman,et al.  Normal needle electromyographic insertional activity morphology: A clinical and simulation study , 1998, Muscle & nerve.

[28]  L. Kunkel,et al.  Caveolin-3 in muscular dystrophy. , 1998, Human molecular genetics.

[29]  F. Zara,et al.  Mutations in the caveolin-3 gene cause autosomal dominant limb-girdle muscular dystrophy , 1998, Nature Genetics.

[30]  D. Stephan,et al.  A rippling muscle disease gene is localized to 1q41 , 1994, Neurology.

[31]  Finsterer Jh,et al.  Obstetrical lumbosacral plexus injury. , 1993 .

[32]  J. Finsterer,et al.  Turn/amplitude-analysis and standardized muscular fatigue in neuromuscular disorders. , 1993, Muscle and Nerve.

[33]  T. Torbergsen.  A FAMILY WITH DOMINANT HEREDITARY MYOTONIA, MUSCULAR HYPERTROPHY, AND INCREASED MUSCULAR IRRITABILITY, DISTINCT FROM MYOTONIA CONGENITA THOMSEN , 1975, Acta neurologica Scandinavica.

[34]  W. Engel,et al.  The histographic analysis of human muscle biopsies with regard to fiber types , 1969, Neurology.